LifeStance Health Gr Q3 2026 Earnings Call Transcript - LifeStance Health Gr (NASDAQ:LFST)

LifeStance Health Gr (NASDAQ:LFST) reported third-quarter 2026 results, with revenue up 25% to $456 million and adjusted EBITDA margin of 15%, according to the earnings call transcript released Thursday. The company raised full-year guidance across all financial metrics, citing strong performance and momentum. LifeStance said it expanded its clinician base to more than 8,800, supporting a scalable model for mental health access. It also highlighted technology progress, including AI and digital tools aimed at improving efficiency and patient reach. Operationally, the firm completed one tuck-in acquisition in Iowa and opened eight new centers. Free cash flow was $22 million, with $219 million cash and $256 million net long-term debt.